(Q28376453)

English

Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 Study Group

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 Study Group (English)

0 references

main subject

phase II clinical trial

0 references

1 reference

C L Shapiro

1

0 references

T Ervin

series ordinal

2

0 references

L Welles

series ordinal

3

0 references

N Azarnia

series ordinal

4

0 references

J Keating

series ordinal

5

0 references

D F Hayes

series ordinal

6

0 references

language of work or name

English

0 references

publication date

May 1999

0 references

published in

Journal of Clinical Oncology

0 references

volume

17

0 references

page(s)

1435-41

0 references

issue

5

0 references

Identifiers

DOI

10.1200/JCO.1999.17.5.1435

0 references

Fatcat ID

release_iv4mbd5t3nbnvlkoojsgu47pwa

0 references

PubMed ID

10334528

0 references

(Q28376453)

Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 Study Group

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)